Clinical Study

Citrus/Cydonia Compositum Subcutaneous Injections versus Nasal Spray for Seasonal Allergic Rhinitis: A Randomized Controlled Trial on Efficacy and Safety

Table 1

Baseline Characteristics (Full Analysis Set).

VariableCitrus/Cydonia comp.GencydoP value
( 𝑛 = 1 2 )( 𝑛 = 1 1 )

Sex: no. (percentage)Male7 (58%)2 (18%).049*
Female5 (42%)9 (82%)
Age (year) (sd)36.8 (12.4)36.9 (10.7).97
Height (cm) (sd)177 (9.5)170.6 (7.4).09
Weight (kg) (sd)70.8 (11.2)66.4 (8.9).3
Smokers: no. (percentage)3 (25%)1 (9%).31
Alcohol consumption: no. (percentage)None 0 (0%)3 (27.3%).15
Occasionally11 (91.7%)7 (63.6%)
Regularly 1 (8.3%)1 (9%)
Ethnic origin: no. (percentage)Caucasian12 (100%)9 (82%).12
Asian 0 (0%)2 (18%)
Childbearing potential:number (percentage)Capable3 (60%)8 (88.9%).31
Sterile1 (20%)1 (11.1%)
Postmenopausal1 (20%)0 (0%)
Blood pressure at screening (mm Hg) (sd)120 (23)/ 73 (14)104 (16)/ 72 (9).09/.77
Heart rate at screening (beats per minute)72 (9)70 (6).56
RAST grass pollen3.7 (1.2)3.9 (1.2).76
RAST birch pollen2.2 (1.8)2.3 (2.1).82
Usual SAR symptom severity during the pollen season (total score anamnestically) (sd)Sneezing2.1 (0.3)2.3 (0.5)
Itching nose1.9 (0.7)2.1 (0.5)
Watery nasal discharge1.9 (0.7)2.1 (0.5)
Total score5.9 (1.4)6.5 (1.2).5
SAR symptom severity scores in the morning during the wash-out period (total score) (sd)6.6 (4.5)8.0 (4.6).55
SAR symptom severity scores in the evening during the wash-out period (total score) (sd)6.1 (3.7)9.7 (5.2).19

* 𝑃 < . 0 5 , ** 𝑃 < . 0 1 , *** 𝑃 < . 0 0 1 .